SE452322B - Kristallina 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-p-toluensulfonat-hydrat och farmaceutiska kompositioner derav - Google Patents
Kristallina 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-p-toluensulfonat-hydrat och farmaceutiska kompositioner deravInfo
- Publication number
- SE452322B SE452322B SE8106404A SE8106404A SE452322B SE 452322 B SE452322 B SE 452322B SE 8106404 A SE8106404 A SE 8106404A SE 8106404 A SE8106404 A SE 8106404A SE 452322 B SE452322 B SE 452322B
- Authority
- SE
- Sweden
- Prior art keywords
- tosylate
- amino
- penicillanate
- phenylacetamido
- crystalline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8035156 | 1980-10-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8106404L SE8106404L (sv) | 1982-05-01 |
SE452322B true SE452322B (sv) | 1987-11-23 |
Family
ID=10517019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8106404A SE452322B (sv) | 1980-10-31 | 1981-10-29 | Kristallina 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-p-toluensulfonat-hydrat och farmaceutiska kompositioner derav |
Country Status (26)
Country | Link |
---|---|
US (1) | US4831025A (xx) |
JP (1) | JPS57126493A (xx) |
KR (1) | KR870001982B1 (xx) |
AT (1) | AT373893B (xx) |
AU (1) | AU543870B2 (xx) |
BE (1) | BE890938A (xx) |
CA (1) | CA1180696A (xx) |
CH (1) | CH647527A5 (xx) |
DE (1) | DE3143219A1 (xx) |
DK (1) | DK154219C (xx) |
ES (1) | ES8206531A1 (xx) |
FI (1) | FI813331L (xx) |
FR (1) | FR2493322B1 (xx) |
GB (1) | GB2114969B (xx) |
GR (1) | GR75369B (xx) |
IE (1) | IE51640B1 (xx) |
IL (1) | IL64009A (xx) |
IT (1) | IT1193735B (xx) |
LU (1) | LU83727A1 (xx) |
NL (1) | NL8104938A (xx) |
NO (1) | NO813683L (xx) |
NZ (1) | NZ198622A (xx) |
PH (1) | PH17820A (xx) |
PT (1) | PT73913B (xx) |
SE (1) | SE452322B (xx) |
ZA (1) | ZA817091B (xx) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4432987A (en) * | 1982-04-23 | 1984-02-21 | Pfizer Inc. | Crystalline benzenesulfonate salts of sultamicillin |
PH20068A (en) * | 1982-12-06 | 1986-09-18 | Pfizer | Process and intermediates for sultamicillin and analogs |
KR910009271B1 (ko) * | 1989-06-20 | 1991-11-08 | 김영설 | 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염 |
ES2161602B1 (es) * | 1999-04-08 | 2003-02-16 | Asturpharma S A | Sintesis de 6-(d-alfa-(bencilidenaminofenilacetamido))penicilanato de 1,1-dioxopenicilanoiloximetilo y analogos. nuevos intermedios para la sintesis de sultamicilina. |
US6627222B2 (en) | 2000-02-24 | 2003-09-30 | Advancis Pharmaceutical Corp. | Amoxicillin-dicloxacillin antibiotic composition |
JP2003523372A (ja) * | 2000-02-24 | 2003-08-05 | アドバンシス ファーマシューティカル コーポレイション | 抗生物質及び抗真菌剤組成物 |
US6565882B2 (en) | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US6730320B2 (en) | 2000-02-24 | 2004-05-04 | Advancis Pharmaceutical Corp. | Tetracycline antibiotic product, use and formulation thereof |
US6667057B2 (en) | 2000-02-24 | 2003-12-23 | Advancis Pharmaceutical Corp. | Levofloxacin antibiotic product, use and formulation thereof |
US7025989B2 (en) * | 2000-02-24 | 2006-04-11 | Advancis Pharmaceutical Corp. | Multiple-delayed released antibiotic product, use and formulation thereof |
US6663890B2 (en) | 2000-02-24 | 2003-12-16 | Advancis Pharmaceutical Corp. | Metronidazole antibiotic product, use and formulation thereof |
US6667042B2 (en) | 2000-02-24 | 2003-12-23 | Advancis Pharmaceutical Corp. | Fluroquinilone antibiotic product, use and formulation thereof |
US6610328B2 (en) | 2000-02-24 | 2003-08-26 | Advancis Pharmaceutical Corp. | Amoxicillin-clarithromycin antibiotic composition |
US6632453B2 (en) | 2000-02-24 | 2003-10-14 | Advancis Pharmaceutical Corp. | Ciprofoxacin-metronidazole antibiotic composition |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6669948B2 (en) | 2000-02-24 | 2003-12-30 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6638532B2 (en) | 2000-02-24 | 2003-10-28 | Advancis Pharmaceutical Corp. | Tetracycline—doxycycline antibiotic composition |
US6991807B2 (en) * | 2000-02-24 | 2006-01-31 | Advancis Pharmaceutical, Corp. | Antibiotic composition |
US6623758B2 (en) | 2000-02-24 | 2003-09-23 | Advancis Pharmaceutical Corp. | Cephalosporin-metronidazole antibiotic composition |
WO2001062229A1 (en) * | 2000-02-24 | 2001-08-30 | Advanced Pharma, Inc. | Therapeutic product, use and formulation thereof |
US6663891B2 (en) | 2000-02-24 | 2003-12-16 | Advancis Pharmaceutical Corp. | Erythromyacin antibiotic product, use and formulation thereof |
US7105174B2 (en) * | 2000-10-13 | 2006-09-12 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-neoplastic product, use and formulation thereof |
US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
US7157095B2 (en) * | 2000-10-13 | 2007-01-02 | Advancis Pharmaceutical Corporation | Multiple-delayed release antifungal product, use and formulation thereof |
US6541014B2 (en) | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
US20020197314A1 (en) * | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
US20040114368A1 (en) * | 2002-12-13 | 2004-06-17 | Shyu Shing Jy | Light device having rotatable or movable view |
US20040265323A1 (en) * | 2003-05-16 | 2004-12-30 | Mccormick Beth A. | Compositions comprising pathogen elicited epithelial chemoattractant (eicosanoid hepoxilin A3), inhibitors thereof and methods of use thereof |
EP1648418A4 (en) | 2003-07-21 | 2011-11-16 | Middlebrook Pharmaceuticals Inc | ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION |
AU2004258953B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
US8313776B2 (en) | 2003-07-21 | 2012-11-20 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
EP1653925A1 (en) | 2003-08-11 | 2006-05-10 | Advancis Pharmaceutical Corporation | Robust pellet |
AU2004264356B2 (en) | 2003-08-12 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
JP5686494B2 (ja) | 2003-08-29 | 2015-03-18 | シオノギ インコーポレイテッド | 抗生物質製剤、その使用法及び作成方法 |
WO2005027877A1 (en) | 2003-09-15 | 2005-03-31 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
JP2008505124A (ja) | 2004-07-02 | 2008-02-21 | アドバンシス ファーマスーティカル コーポレイション | パルス送達用錠剤 |
WO2007004239A1 (en) * | 2005-07-06 | 2007-01-11 | Morepen Laboratories Limited | New polymorphic form of sultamicillin tosylate and a process therefor |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8299052B2 (en) * | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
AU2013290827B2 (en) | 2012-07-17 | 2018-10-18 | Elanco New Zealand | Injectable antibiotic formulations and their methods of use |
EP2874624B8 (en) | 2012-07-17 | 2019-10-02 | Bayer New Zealand Limited | Injectable antibiotic formulations and their methods of use |
US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1532222A (fr) * | 1963-10-28 | 1968-07-12 | Bristol Myers Co | Procédé de préparation de dérivés de la pénicilline |
BE881675A (fr) * | 1979-02-13 | 1980-08-12 | Leo Pharm Prod Ltd | B-lactames derives de l'acide penicillanique leur preparation et leurs utilisations therapeutiques |
IE49880B1 (en) * | 1979-02-13 | 1986-01-08 | Leo Pharm Prod Ltd | Penicillin derivatives |
US4244951A (en) * | 1979-05-16 | 1981-01-13 | Pfizer Inc. | Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide |
IE51516B1 (en) * | 1980-10-06 | 1987-01-07 | Leo Pharm Prod Ltd | 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate |
-
1981
- 1981-10-06 IL IL64009A patent/IL64009A/xx not_active IP Right Cessation
- 1981-10-08 IE IE2361/81A patent/IE51640B1/en not_active IP Right Cessation
- 1981-10-13 NZ NZ198622A patent/NZ198622A/en unknown
- 1981-10-14 GB GB08131010A patent/GB2114969B/en not_active Expired
- 1981-10-14 ZA ZA817091A patent/ZA817091B/xx unknown
- 1981-10-15 AU AU76365/81A patent/AU543870B2/en not_active Expired
- 1981-10-19 PH PH26362A patent/PH17820A/en unknown
- 1981-10-20 AT AT0447781A patent/AT373893B/de not_active IP Right Cessation
- 1981-10-23 FI FI813331A patent/FI813331L/fi not_active Application Discontinuation
- 1981-10-23 IT IT68383/81A patent/IT1193735B/it active
- 1981-10-26 CA CA000388756A patent/CA1180696A/en not_active Expired
- 1981-10-27 DK DK472181A patent/DK154219C/da not_active IP Right Cessation
- 1981-10-29 SE SE8106404A patent/SE452322B/sv not_active IP Right Cessation
- 1981-10-29 GR GR66381A patent/GR75369B/el unknown
- 1981-10-30 KR KR1019810004171A patent/KR870001982B1/ko active
- 1981-10-30 JP JP56175559A patent/JPS57126493A/ja active Granted
- 1981-10-30 NL NL8104938A patent/NL8104938A/nl active Search and Examination
- 1981-10-30 ES ES506751A patent/ES8206531A1/es not_active Expired
- 1981-10-30 LU LU83727A patent/LU83727A1/fr unknown
- 1981-10-30 DE DE19813143219 patent/DE3143219A1/de active Granted
- 1981-10-30 NO NO813683A patent/NO813683L/no unknown
- 1981-10-30 CH CH6947/81A patent/CH647527A5/de not_active IP Right Cessation
- 1981-10-30 BE BE0/206403A patent/BE890938A/fr not_active IP Right Cessation
- 1981-10-30 PT PT73913A patent/PT73913B/pt unknown
- 1981-10-30 FR FR8120476A patent/FR2493322B1/fr not_active Expired
-
1987
- 1987-03-13 US US07/024,858 patent/US4831025A/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE452322B (sv) | Kristallina 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-p-toluensulfonat-hydrat och farmaceutiska kompositioner derav | |
JPH0314811B2 (xx) | ||
CN1382682A (zh) | 2-(α-羟基戊基)苯甲酸盐及其制法和用途 | |
JPS6020394B2 (ja) | 抗生物質の製造方法 | |
JPS60174783A (ja) | 新規8α‐アシルアミノエルゴリン類 | |
SE452323B (sv) | Kristallint 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-2-naftensulfonat och farmaceutiska kompositioner derav | |
CN1064681C (zh) | 杂环化合物 | |
KR870000291B1 (ko) | 결정상 벤조티아진 디옥사이드 염의 제조방법 | |
RU2515557C9 (ru) | Фармацевтическая соль 8-метил-7-[5-метил-6-(метиламино)-3-пиридинил]-1-циклопропил-4-оксо-1,4-дигидро-3-хинолинкарбоновой кислоты, ее содержащая фармацевтическая композиция, лекарственное средство и способ лечения или профилактики бактериальных инфекций с помощью вышеуказанной соли | |
ZA200508640B (en) | Crystal of benzimidazole derivative and process for producing the same | |
JPS6011040B2 (ja) | 抗菌剤類の製法 | |
JPH10195076A (ja) | 結晶形態のカルバペネム化合物 | |
US4464379A (en) | Indol acetic acid derivatives and anti-inflamatory and related uses thereof | |
GB2084572A (en) | 1,1-Dioxopenicillanoyloxymethyl 6-(D- alpha -amino- alpha -phenylacetamido)penicillanate napsylate | |
JP3148235B2 (ja) | 抗菌性ペネム化合物 | |
US3253990A (en) | N-methyl glucammonium salicylate and uses therefor | |
JP3242975B2 (ja) | 消化管運動機能改善剤 | |
JP2739328B2 (ja) | ベンズイミダゾール化合物の精製方法 | |
JP3274855B2 (ja) | 抗菌性ペネム化合物 | |
JPH09124653A (ja) | 水和物結晶及びその製造方法 | |
HU203869B (en) | Process for producing salts ofnew acrylic acid derivatives and pharmaceutical compositions containing them | |
IE43950B1 (en) | New 6-amidinopenicillanic acid derivatives | |
JPS63190886A (ja) | 2−アミノ−1,3,4−チアジアゾ−ル誘導体および該誘導体を有効成分とする抗潰瘍剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8106404-0 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8106404-0 Format of ref document f/p: F |